New York, August 24, 2015 -- Moody's Investors Service commented on DaVita HealthCare Partners Inc.'s announcement that it has entered into an agreement to acquire Renal Ventures, LLC for $415 million is credit positive. Given DaVita's cash and short-investment balance of about $1.8 billion for the period ended June 30, 2015, Moody's expects the transaction to be funded mostly with existing cash and to be leverage neutral (4.1 times debt to EBITDA as of June 30, 2015). The acquisition is expected to close by the end of fiscal 2015.
Vollständigen Artikel bei Moodys lesen
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.